Segui
Charles Chesnelong
Charles Chesnelong
Email verificata su ucalgary.ca
Titolo
Citata da
Citata da
Anno
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers
S Yip, YS Butterfield, O Morozova, S Chittaranjan, MD Blough, J An, I Birol, ...
The Journal of pathology 226 (1), 7-16, 2012
3372012
Lactate dehydrogenase A silencing in IDH mutant gliomas
C Chesnelong, MM Chaumeil, MD Blough, M Al-Najjar, OD Stechishin, ...
Neuro-oncology 16 (5), 686-695, 2014
1942014
An in vivo patient-derived model of endogenous IDH1-mutant glioma
HA Luchman, OD Stechishin, NH Dang, MD Blough, C Chesnelong, ...
Neuro-oncology 14 (2), 184-191, 2011
1912011
Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1
T Mazor, C Chesnelong, A Pankov, LE Jalbert, C Hong, J Hayes, ...
Proceedings of the National Academy of Sciences 114 (40), 10743-10748, 2017
1332017
Hyperpolarized 13C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring
MM Chaumeil, M Radoul, C Najac, P Eriksson, P Viswanath, MD Blough, ...
NeuroImage: Clinical 12, 180-189, 2016
672016
Precursor states of brain tumor initiating cell lines are predictive of survival in xenografts and associated with glioblastoma subtypes
C Cusulin, C Chesnelong, P Bose, M Bilenky, K Kopciuk, JA Chan, ...
Stem cell reports 5 (1), 1-9, 2015
632015
Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival
P Guilhamon, C Chesnelong, MM Kushida, A Nikolic, D Singhal, ...
Elife 10, e64090, 2021
592021
Spontaneous loss of heterozygosity leading to homozygous R132H in a patient-derived IDH1 mutant cell line
HA Luchman, C Chesnelong, JG Cairncross, S Weiss
Neuro-oncology 15 (8), 979-980, 2013
452013
ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways
F Wang, AY Wang, C Chesnelong, Y Yang, A Nabbi, S Thalappilly, ...
Oncogene 37 (3), 286-301, 2018
362018
DNA hypermethylation and 1p Loss silence NHE‐1 in oligodendroglioma
MD Blough, M Al‐Najjar, C Chesnelong, CE Binding, AD Rogers, ...
Annals of neurology 71 (6), 845-849, 2012
302012
SLUG directs the precursor state of human brain tumor stem cells
C Chesnelong, X Hao, O Cseh, AY Wang, HA Luchman, S Weiss
Cancers 11 (11), 1635, 2019
182019
Isolation and culture of glioblastoma brain tumor stem cells
C Chesnelong, I Restall, S Weiss
Brain Tumor Stem Cells: Methods and Protocols, 11-21, 2019
142019
Live-Cell imaging assays to study glioblastoma brain tumor stem cell migration and invasion
I Restall, DA Bozek, C Chesnelong, S Weiss, HA Luchman
JoVE (Journal of Visualized Experiments), e58152, 2018
112018
Isocitrate Dehydrogenase (IDH) Mutation in Gliomas
C Chesnelong
Next Generation Sequencing in Cancer Research, Volume 2: From Basepairs to …, 2015
22015
STAT3 is a key regulator of an “EMT-like” process mediated by Slug in GBM
C Chesnelong, HA Luchman, JG Cairncross, S Weiss
Cancer Research 76 (14_Supplement), 2524-2524, 2016
12016
STEM-11. POLYAMINE METABOLISM AND INFLAMMATORY STATE CONTROL A VIRAL MIMICRY-DRIVEN QUIESCENT PHENOTYPE IN GLIOMA STEM CELLS (GSCS)
C Chesnelong, C Charton, P Dirks
Neuro-Oncology 24 (Suppl 7), vii33, 2022
2022
Henry Ford Health System Scholarly Common s
S Arora, C Bronkema, JR Porter, A Mottrie, M Menon
Laboratory Investigation 101 (1), 499-501, 2021
2021
Molecular Pathways to Initiation and Progression in Gliomas
C Chesnelong
2017
STAT3 REGULATES AN SL/PL TRANSITION IN BTICs THROUGH AN EMT-LIKE PROCESS MEDIATED BY SLUG
C Chesnelong, HA Luchman, JG Cairncross, S Weiss
NEURO-ONCOLOGY 18, 39-40, 2016
2016
Hyperpolarized C-13 MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring
S Ronen, MM Chaumeil, M Radoul, C Najac, P Eriksson, P Viswanath, ...
2016
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20